Latest FrostPharma News & Updates

See the latest news and media coverage for FrostPharma. We track all announcements, press releases, and industry mentions in real time, all in one place.

FrostPharma

Specialty pharmaceutical company

frostpharma.com

Headquarters: Danderyd, Sweden
Founded year: 2010
Company type: Public company
Number of employees: 40–50

Last updated Today

Latest news about FrostPharma

In short: FrostPharma expanded its leadership team, launched new ADHD treatments, and merged with Abboxia to strengthen its Nordic market presence.

Company announcements

January 14 FrostPharma

FrostPharma launches Silarosa in Norway

The lisdexamfetamine oral solution targets children and adolescents with ADHD, improving adherence and safer treatment. It marks a milestone toward Nordic leadership.

13 October 2025 FrostPharma

FrostPharma reintroduces DESIVON in Sweden

From October, DESIVON is available at over 1,000 pharmacies in Sweden, including Apoteket AB, Apotek Hjärtat, and Kronans Apotek. The plan is to reach Swedish households.

29 September 2025 FrostPharma

FrostPharma appoints Magnus Nylén as new CEO

Magnus Nylén comes from Bohus BioTech and has previously been manager at Trimb, Actavis and Karo Healthcare. Fredrik Andersch continues as business development manager and strengthens M&A.

2 September 2025 FrostPharma

FrostPharma launches new website and FrostPharmaPRO

The site focuses on simplicity and user-friendliness for partners, healthcare professionals, and the general public. FrostPharmaPRO.com provides in-depth information and resources for clinical work.

Media coverage

6 October 2024 Dagens Juridik

Law firm Lindahl has represented the sellers of Abboxia in the strategic merger with FrostPharma. The two companies are now merging under the name FrostPharma and thereby become..

Law firm Lindahl has represented the sellers of Abboxia in the strategic merger with FrostPharma. The two companies are now merging under the name FrostPharma and thereby become...

6 October 2021 Business Wire

Advicenne Announces the Launch of Sibnayal ® in Denmark

PARIS--(BUSINESS WIRE)--Regulatory News: Advicenne (Euronext Growth Paris ALDVI - FR0013296746), a specialty pharmaceutical company dedicated to the development and commercialization of innovative treatments for those...

Never miss news about FrostPharma

Track FrostPharma and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

FrostPharma competitors & trending companies

Browse news for competitors to FrostPharma and other trending companies.